Tislelizumab combined with chemotherapy shows promising antitumor activity in advanced cervical cancer, achieving high response rates and manageable safety profiles.

The single mom had not had a Pap smear for 22 years because she was busy raising her kids. She urges others to prioritize ...

ACCURATELY predicting which breast cancer patients will respond completely to neoadjuvant chemotherapy (NAC) remains a ...

What is cervical cancer? The cervix is the opening of the uterus, and cervical cancer means malignant cells are found in tissues there. In the United States, it's one of the most common cancers ...

US FDA grants fast track designation to DualityBio's next-generation HER3 ADC DB-1310 to treat nonsquamous non-small cell lung cancer ...

However, the rising number of cervical cancer cases, particularly among young girls, has raised alarm across public health circles. Pakistan now ranks seventh globally in cervical cancer prevalence.

ADRX-0405 is a clinical-stage next-generation ADC targeting six-transmembrane epithelial antigen of the prostate 1 (STEAP1), a cell surface protein that is upregulated in prostate cancer and ...

IDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849), a Potential First-in-Class DLL3-TOP1 ADC ...